Delcath Completes Enrollment in its United States Registration Pivotal Trial (FOCUS) Investigating Melphalan/HDS in the Treatment of Patients with Unresectable Hepatic-Dominant Ocular Melanoma
January 13, 2020 08:30 ET | Delcath Systems, Inc.
NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today...
Delcath Systems Announces 1-for-700 Reverse Stock Split to be Effective on December 24, 2019
December 19, 2019 08:30 ET | Delcath Systems, Inc.
NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that...
Delcath Systems to Present at the 12th Annual LD Micro Main Event on December 10, 2019
December 03, 2019 08:30 ET | Delcath Systems, Inc.
NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced...
Delcath Systems Announces Postponement of Reverse Stock Split
October 22, 2019 07:27 ET | Delcath Systems, Inc.
NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Systems Announces Ratio for Reverse Stock Split
October 18, 2019 08:00 ET | Delcath Systems, Inc.
NEW YORK, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Systems to Present at the MicroCap Rodeo Investor Conference
October 08, 2019 08:00 ET | Delcath Systems, Inc.
NEW YORK, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will present at the MicroCap Rodeo. The conference will be held October...
Delcath Systems to Participate in Upcoming Investor Conferences
September 23, 2019 11:30 ET | Delcath Systems, Inc.
NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will participate at the following upcoming investor conferences in New...
Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright
August 28, 2019 08:00 ET | Delcath Systems, Inc.
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will present at the Rodman & Renshaw 21st Annual Global Investment...
Delcath Systems Closes $9.5 Million Private Placement
August 20, 2019 08:00 ET | Delcath Systems, Inc.
Bringing total financial amount raised since July 2019 to $29.5M Cash runway past top-line results in 1H2020 with NDA submission anticipated by end of 2020 Recapitalization provides possible...
Delcath Systems Announces $9.5 Million Private Placement
August 15, 2019 18:02 ET | Delcath Systems, Inc.
NEW YORK, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH)) today announced that it has entered into a definitive agreement for...